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Abstract
Adult stem cells are present in many tissues including, skin, muscle, adipose, bone marrow, and in the brain.
Neuroinflammation has been shown to be a potent negative regulator of stem cell and progenitor cell proliferation in the
neurogenic regions of the brain. Recently we demonstrated that decreasing a key neuroinflammatory cytokine IL-1b in the
hippocampus of aged rats reversed the age-related cognitive declineandincreased neurogenesis intheagerats. Wealsohave
foundthatnutraceuticalshavethepotentialtoreduce neuroinflammation,anddecreaseoxidative stress.Theobjectivesofthis
study were to determine if spirulina could protect the proliferative potential of hippocampal neural progenitor cells from an
acute systemic inflammatory insult of lipopolysaccharide (LPS). To this end, young rats were fed for 30 days a control diet or a
diet supplementedwith 0.1% spirulina. Onday28therats were given a singlei.p.injectionof LPS (1 mg/kg). Thefollowing day
the rats were injected with BrdU (50 mg/kg b.i.d. i.p.) and were sacrificed 24 hours after the first injection of BrdU.
Quantification of the BrdU positive cells in the subgranular zone of the dentate gyrus demonstrated a decrease in proliferation
of the stem/progenitor cells in the hippocampus as a result of the LPS insult. Furthermore, the diet supplemented with
spirulina was able to negate the LPS induced decrease in stem/progenitor cell proliferation. In a second set of studies we
examined the effects of spirulina either alone or in combination with a proprietary formulation (NT-020) of blueberry, green
tea, vitamin D3 and carnosine on the function of bone marrow and CD34
+ cells in vitro. Spirulina had small effects on its own
and more than additive effects in combination with NT-020 to promote mitochondrial respiration and/or proliferation of these
cells in culture. When examined on neural stem cells in culture spirulina increased proliferation at baseline and protected
against the negative influenceof TNFa to reduce neuralstem cell proliferation.Theseresultssupportthe hypothesis thatadiet
enriched with spirulina and other nutraceuticals may help protect the stem/progenitor cells from insults.
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Introduction
Neurogenesis is a life-long occurrence that is limited to specific
sites within the brain; namely, the subventricular zone (SVZ), and
the subgranular zone (SGZ) of the hippocampus. The de novo
production of new neurons into the hippocampus, has been shown
to be important for some forms of learning [1]. While numerous
studies have shown that neurogenesis is physiologically relevant for
cognitive function, the relationship is complex (For review see:
[2,3]). Nonetheless, neurogenesis is clearly linked to plasticity and
repair mechanisms [4] and alterations in neurogenesis have been
also been attributed to some affective disorders [5].
Two seminal studies, published simultaneously, a number of
years ago showed that inflammation tightly regulates neurogenesis
in the SGZ [6,7]. Ekdahl et al. (03) used LPS that they delivered
into the cortex continuously by an osmotic mini pump. In the
young adult rat, LPS-induced inflammation resulted in an 85%
reduction in the number of new neurons born during the
inflammatory insult [6]. Monje et al. (03) also found that LPS
given systemically caused an increase in microglia activation and a
decrease in neurogenesis, which could be prevented by the
nonsteroidal anti-inflammatory drug (NSAID) indomethacin [7].
Cytokines do appear capable of regulating several phases of the
neurogenesis process. At low concentrations the proinflammatory
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(NPC), but at higher concentrations TNF-a results in program cell
death [8]. TNF-a induced program cell death in the NPC is
dependent on TNF receptor 1 (TNF-RI) [9] which is constitutively
expressed by NPC in culture [10]. IL-1b can also directly suppress
neurogenesis by blocking the production of cyclic dependent
kinesis [10,11]. Inflammation also alters the way the new neurons
integrate into the existing neuronal circuit [12].
We have previously demonstrated that spirulina can act as an
anti-inflammatory, and reverse the age-related elevation of TNF-a
[13]. Activation of TNF-RI by TNF-a negatively regulates the
proliferation of NPC [10]. Therefore we hypothesized that
spirulina could protect against an acute systemic inflammatory
insult induced by LPS the effects would occur during the
proliferative phase of neurogenesis. To test this hypothesis, young
adult Fisher 344 rats were fed a control diet, or a diet
supplemented with 0.1% spirulina for 28 days before administra-
tion of LPS. As predicted, LPS decreased proliferation of the
hippocampal NPCs. Spirulina was able to prevent the LPS
induced decrease in NPC proliferation. The LPS insult did not
appear to have pronounced affects on microglial activation but did
produce a measurable increase in astrogliosis. Pretreatment with
spirulina also blocked the LPS induced astrogliosis. The in vivo
results suggest that spirulina protects by a non-stem cell
autonomous mechanisms.
Previous studies have shown that nutraceuticals can have effects
on adult stem cells. A nutraceutical combination of blueberry
extract, green tea extract, carnosine, and vitamin D3 (a
proprietary formulation known as NT-020) has been shown to
promote migration of brain stem cells from the stem cell niche to
the site of injury in an animal model of stroke [4]. NT-020 was
shown to stimulate the proliferation of human stem cells derived
from bone marrow; bone marrow derived CD34
+ and progenitor
cells from peripheral blood (CD133
+) in vitro [14]. Cultured bone
marrow cells removed from mice given NT-020 orally for 2 weeks
exhibited a dose-related reduction of oxidative stress-induced cell
death. This demonstrates that the action of this nutraceutical on
stem cells is not dependent on the presence of the formulation as
the effect was observed when the cells were cultured in the absence
of NT-020 for 3 days.
To investigate if spirulina could promote proliferation of cells
other than neural stem cells investigated the effects of spirulina
both alone and in combination with NT-020 to promote the
proliferation of bone marrow and CD34
+ stem cells in culture as
measured with MTT. We found that spirulina increased
proliferation/mitochondrial respiration of CD34
+ stem cells in
culture. The results of this study demonstrate that spirulina can
negate the negative effects of inflammation on neurogenesis,
indirectly by decreasing astrogliosis and by potentially acting
directly on the stem cells and promote proliferation of bone
marrow and CD34+ human stem cells in culture.
Results
Spirulina protects against LPS induced decrease in
hippocampal progenitor cell proliferation
Before induction of the LPS inflammatory insult, young adult
male Fisher 344 rats were fed either a standard NIH-31 diet or a
spirulina-enriched diet (NIH-31 +0.1% spirulina). After 28 days on
the diets the rats were injected with LPS (1 mg/kg) into the
peritoneal cavity to induce an acute inflammatory insult. The
following day, day 29, the rats were injected twice (8 hours
interval) with BrdU (50 mg/kg) to label those cells that were
proliferating while BrdU was available. The rats were then
euthanized on the following day to determine if spirulina could
protect against the anti-neurogenic effects of LPS (see Fig. 1A for
timeline). Quantification of the BrdU labeled cells, in the SGZ of
the hippocampus, was performed using the optical fractionator
method of design based stereology [15]. A significant effect was
found (F(2,19)=5.913, p,0.05) in the number of BrdU
+ cells in the
SGZ in the rats euthanized two days after the inflammatory insult
of LPS (Fig. 1A). As we predicted, LPS did significantly decrease
the number of BrdU
+ cells in the rats fed the control diet
(t(10)=3.589; p=0.0049). The cytokine storm induced by LPS
peaks 2 hours after intraperitoneal injection of LPS [16], we found
that even one full day after the peak of the cytokine storm,
proliferation of the NPC was reduced by nearly 40% in rats fed the
control diet. A diet enriched with spirulina was able to completely
prevent the LPS induced decrease in NPC proliferation. In rats fed
a spirulina enriched diet prior to being injected with LPS,
proliferation of NPC was not significantly different then the
control fed rats that were not injected with LPS. Moreover, in
comparison to the control fed rats that were injected with LPS, the
spirulina fed rats that were also injected with LPS had significantly
more BrdU labeled cells in the SGZ (t(12)=3.113; p=0.0090).
The incorporation of BrdU in the DNA can occur in any cell
that is actively synthesizing DNA. While incorporation of BrdU
can occur in cells that are repairing DNA, it has been
demonstrated that the amount of BrdU added to DNA during
the repair process is typically below the level necessary to be
detected by standard immunohistochemistry procedures [17].
BrdU does not discriminate proliferating neurons or glia. As LPS
could increase the proliferation of glia, particularly microglia,
confocal microscopy was used to determine if the BrdU was
labeling glia. Figure 2 and 3, show the photomicrographs of BrdU
(red) and Iba-1 (green). Iba-1 is a calcium-binding protein that is
restrictedly expressed in macrophages/microglia [18]. In the
neurogenic region of the hippocampus, BrdU+ cells were not
found to be double labeled with Iba-1 to any measurable extent in
control fed rats without LPS or in spirulina fed rats with LPS.
However, in the control fed rats that were injected with LPS some
Figure 1. Spirulina protects against LPS induced decrease in
cell proliferation. (A) Results of the Stereological counts of the
number of BrdU
+ cells demonstrated that spirulina was able completely
block the LPS induced decline in inflammation. *** p=0.0049 (NIH-31
vs. NIH-31+LPS). {{{ P=0.0090 (NIH-31+LPS vs. spirulina+LPS). (B)
Shows the representative BrdU staining in the rats without LPS. (C)
After LPS in the rats fed the control diet there are fewer BrdU
+ cells. (D)
In the spirulina fed rat LPS did not cause a decrease in proliferation. (All
photomicrographs taken at 106magnification).
doi:10.1371/journal.pone.0010496.g001
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+ cells were found in the SGZ that were double-labeled with
Iba-1 (Fig. 2D–E, Fig. 3G–I).
The stem cell/progenitor cell in the brain is proposed to be of
an astrocyte lineage. However, the GFAP
+ stem cell is less
proliferative then the transient amplifying cell, and normally
accounts for a small percentage of the proliferating cells. Figure 4
shows photomicrographs of BrdU (red) and GFAP (green)
immunofluorescence staining. In the all three groups very few of
the BrdU+ cells were found to be double labeled with GFAP.
There did not appear to be any differences between groups in the
number of BrdU
+/GFAP
+ cells; however, the relative scarcity of
double labeled cells made it impossible to make reliable statistical
comparisons between groups.
Spirulina does not alter microglia response to LPS
The expression of MHC Class II on microglia is not constitutive
but is inducible upon microglia activation. The number of cells
expressing MHC Class II was quantified using the marker OX-6.
Initialanalysis of OX-6 expressiondemonstrated relatively few OX-
6
+ cells in any of the treatment groups. To limit errors due to under-
sampling the entire hippocampus was used as the area sampling
fraction. In rats that did not receive LPS there was no detectable
OX-6
+ cells in the hippocampal parenchyma. While still rare, OX-
6
+ cells were seen in association with blood vessels, indicating that
the lack of OX-6
+ cells was not due to poor staining. In the LPS
treat rats, OX-6+ cells were found in the hippocampal parenchyma;
however, there was still very few OX-6
+ cell, resulting in large
amountofintragroup variability.Nostatistical difference wasfound
in the rats that received LPS and fed either a diet enriched with
spirulina or a control diet (data not shown).
Spirulina protects from LPS induced astrogliosis
Astrocyte activation has been demonstrated to accompany a
neuronal insult [19]. Elevation in the expression of glial fibrillary
acidic protein (GFAP) has been used to demonstrate an increase in
activated astrocytes. Increased GFAP immunoreactivity is believed
to occur due to increased expression on existing cells and not due to
an increase in the number of astrocytes. To quantify the expression
of GFAP in the dentate gyrus we used the design-based stereological
probe, area fraction fractionator. Quantification of the per-
centage of the dentate gyrus that was immunoreactive for GFAP
revealed a significant effect of treatment (F(2, 14)=24.04, p,0.0001;
Figure 5.A). LPS induced a significant increase in percentage of the
dentate gyrus that was occupied by GFAP immunoreactivity in
control diet fed rats (t(8)=6.496; p=0.0002). Spirulina was able to
prevent the LPS induced increase GFAP immunoreactivity. There
was no significant difference between the rats that were control rats
that did not receive LPS and the spirulina fed rats that did receive
LPS. Moreover, the spirulina fed rats that received the LPS insult
had significant less astrogliosis then the matched control rats that
received LPS (t(9)=5.683; p=0.0003). Using the optical fraction-
ator method of design based stereology we also quantified the total
number of GFAP
+ cells in the dentate gyrus. While there was a
significant increase in the area of the dentate gyrus that was GFAP
Figure 2. BrdU found in microglia only in the control fed mice following LPS. Low magnification confocal photomicrographs were used to
determine if the BrdU was labeling non-neural cells. (A–C) In the control animals without LPS the majority of the BrdU cells were not found to be
microglia. (D–E) In the control diet fed rats treated with LPS note that fewer BrdU cells were found and that many of the BrdU labeled cells were
microglia. White arrow shown in high magnification in Fig. 3D–F Yellow arrow shown in high magnification in Fig. 3G–I. (G–I) In the spirulina fed rats
the BrdU cells were not found to be microglia.
doi:10.1371/journal.pone.0010496.g002
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+
astrocytes following the LPS induced inflammatory insult
(Figure 5.B). Therefore after the LPS insult the increase in
astrogliosis was due to an increase activation of GFAP in existing
cells. In support that there was not an increase in the number of
astrocytes we did not find an increase in GFAP
+/BRDU
+ cells in
the dentate gyrus in any of the groups (Fig. 4). The non-significant
increase in the number GFAP
+ cells in the dentate gyrus of the LPS
treated control fed rats is most likely a result of an increase in GFAP
expression in cells that would have otherwise been undetectable.
Spirulina increases proliferation/mitochondrial function
of human stem cells in culture
We analyzed the effects of spirulina on human neural
progenitor cells and human bone marrow and CD34
+ cells in
culture to determine if spirulina could have a potentially direct
effect on the proliferation of stem cells. Using this assay we
previously found that NT-020 could promote proliferation of bone
marrow and bone marrow derived CD34
+ progenitors and
progenitor cells from peripheral blood (CD133
+) in vitro [14].
Using this previously validated assay, human bone marrow cells
were grown in culture with either spirulina alone, NT-020 alone,
or spirulina in combination with NT-020 added to the culture
media for 72 hours. A significant effect was found in the bone
marrow cells proliferation assay (F(5,35)=166.8, p,0.0001;
Fig 6.A). Replicating previously published results, NT-020
significantly increased proliferation of bone marrow cells
(p,0.001; Fig 6A) [14]. Spirulina alone at concentrations of
62 ng/ml (p,0.001) and 125 ng/ml (p,0.001) significantly
increased proliferation of bone marrow cells in culture when
Figure 3. Orthogonal projections of BrdU IBA1 co-staining. (A–C) shows a representative cluster of BrdU
+ cells in the SGZ confirming the cells
are not microglia by the lack of colocalization with IBA-1. (D–E) shows a cluster of BrdU
+ cells in the LPS treated rats that are not microglia. (G–I)
shows a BrdU
+ that does double label with the microglia marker IBA-1 as noted by the yellow color in the merged panel. (J–K) shows BrdU and IBA-1
staining in the Spirulina fed rats. Note, in this and all confocal images the side panels for each box are 90u rotations of the Z-stacks for confirmation of
double labeling.
doi:10.1371/journal.pone.0010496.g003
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spirulina (125 ng/ml) was combined with NT-020 the combined
group was significantly different from NT-020 alone (p,0.001).
Moreover the effect on cell proliferation was 50% greater then
what would be expected if the increase in proliferation was an
additive effect. One caveat to take into consideration when
considering these results is that the MTT assay measures
mitochondrial function and thus is an indirect measure of
proliferation, thus if a primary effect of these treatments is an
increase in mitochondrial respiration, then this may exaggerate the
conclusion of proliferative effects of this treatment.
Bone marrow cells are a mixed population of stem cells,
immature and mature hematopoietic cells, thus we also examined
the effect of spirulina on isolated human peripheral blood CD34
+
stem cells (Fig. 6.B). Replicating the effects of the bone marrow
cells, a significant effect was found in the CD34
+ cells in the
proliferation assay (F(5,27)=166.8, p,0.0001; Fig 6.B). At
concentrations of spirulina 62 ng/ml or higher significant increase
in proliferation of CD34
+ stem cells in culture was found
(p,0.001). When examined in combination with NT-020 there
was also an additive effect of spirulina (125 ng/ml) on NT-020 in
the CD34
+ stem cells p,0.001).
We next examined the effects of the most effective dose of
spirulina (125 ng/ml) and or NT-020 in the presence or absence of
TNFa to determine if the effects observed in vivo to promote
neurogenesis would be observed in vitro. In Figure 7A a significant
effect was found by MTT assay (F(7,57)=59.83, p,0.0001). It can
be observed that spirulina and NT-020 both increase proliferation
of human neural stem cells in culture at baseline when measured
with the MTT assay. When TNFa was added to the media this
reduced the proliferation by approximately 40%, however
spirulina, but not NT was able to block this effect in vitro. In
the human neural stem cells as opposed to the hematopoetic stem
cells there was no additive effect of spirulina and NT-020. To
determine if this effect was also observed with a more direct
measure of proliferation duplicate cultures were quantified for
proliferation using BrdU. As can be observed in Figure 7B a
significant effect was found by BrdU (F(7,47)=252.4, p,0.0001).
These data reflect that spirulina and NT-020 increased the
numbers of cells dividing in these cultures and that TNFa reduced
the proliferation of cells and that spirulina but not NT-020 had an
effect to reduce the inhibition by TNFa.
Discussion
Inflammation is an active process with the purpose of removing
or inactivating potentially damaging agents. LPS induces a
microbial defense immunity, resulting in the activation of pro-
inflammatory pathways, producing inflammatory mediators in-
cluding cytokines and chemokines. The response to eliminate the
‘danger signals’ does not discriminate and will also cause damage
to the uninfected tissue. A failure to regulate inflammation
following response to ‘danger signals’ may lead to chronic
pathology. We demonstrate that spirulina, a blue-green algae,
was able to negate the deleterious effects of LPS induced
inflammation on NPC function, by maintaining the proliferative
ability of the NPCs in the face of an acute inflammatory insult.
Many degenerative diseases and normal aging lead to an
inflammatory condition, thus this regulation of the immune
response is important under many different kinds of pathological
conditions.
The main cell type in the CNS that is responsible for immunity
is the microglia. LPS, up-regulates the production of IL-1b by
microglia [20]. In our study, we gave only one i.p. injection of
LPS, following which we euthanized the rats two days after the
LPS insult. At 48 hours after the LPS we did not find an increase
in microglia activation as determined by the induction of MHC
class II expression. Effects of LPS on microglia are observed at
Figure 4. Orthogonal projections of BrdU GFAP co-staining. (A–D) Confocal images with orthogonal views demonstrate the absence of co-
labeling of BrdU and GFAP in the 4 groups of animals examined. In the merged column you can observe co-localization of BrdU with DAPI as
indicated by the purple. In constrast there is no colocalization of BrdU with GFP although the GFP labeled cells are closely associated with the BrdU
positive cells. This supports our finding of no increased absolute numbers of GFAP labeled cells between any of the groups examined.
doi:10.1371/journal.pone.0010496.g004
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reason we did not observe an increase was that this phase of
activation ends prior to 48 hours post LPS insult. Cytokines such
as IL-1b, and TNF-a can also act in an autocrine or paracrine
manner to increase the production of IL-1b by microglia [20].
Microglia are the main source of inflammatory cytokines, but
astrocytes and neurons can also make inflammatory mediators
[21]. Astrocytes can also be stimulated by IL-1b, but not by LPS,
to produce TNF-a and IL-6. The secondary response to LPS in
astrocytes to microglial produced IL-1b results in increased
production of TNF-a beginning about 8 hours, and lasting of
72 hours, and with IL-6 production is still increasing at 72 hour
time point [20]. At 48 hours the inflammatory response following
LPS has likely transitioned from the initial response of microglia to
a secondary response produced by astrocytes. BrdU was injected
in the rats at 24 hours after the LPS insult. The decrease in BrdU
cell number in the LPS treated rats on the control diet could have
been from the initial response of microglia to the LPS or from the
secondary response of astrocytes to microglia produced inflam-
matory mediators. It is not possible, from the results of our study,
to determine if the decrease in the number of BrdU
+ cell was from
the initial response of microglia or the secondary response with
astrocytes. At 48 hours after LPS there was a measurable
astrogliosis in rats on the control diet, but not in rats on the
spirulina diet.
Spirulina has been shown to have anti-inflammatory and anti-
oxidant effects [13]. The nonsteroid anti-inflammatory drug
(NSAID), indomethacin, has been shown able to block the
microglia activation and decreased neurogenesis produced by
LPS [7]. NSAIDs typically act by blocking cyclooxygenase (COX)
activity. The anti-inflammatory properties of spirulina may be
attributed to inhibition of COX-2 activity [22] or due the ability to
scavenge free radicals [13]. Spirulina has also been shown to
enhance innate and adaptive immunity. Immolina, a high
molecular weight extract of spirulina, has been shown in vitro to
be a potent activator of NF-kappa-B in monocytes/macrophages
leading to increased IL-1b and TNF-a [23]. The effects of
immolina were mediated through the toll like receptor (TLR)-2
and not TLR-4 [24]; therefore it is unlikely that spirulina is acting
as a competitive antagonist to the binding of LPS to TLR-4.
However, extracting immolina from spirulina might alter the
bioactivity of spirulina. Unlike NSAIDs, which act to suppress the
immune activation, spirulina may be enhancing the innate
immunity resulting in a quicker removal of ‘danger signals’. This
effect may be due to priming of the monocytes/macrophages to
activation of the TLR [24]. Spirulina has been shown to enhance
phagocytosis in macrophages [25,26,27] as well as, enhancing
cellular and humoral adaptive immunity [25,28,29]. To the best of
our knowledge, there has been no in vivo study to determination of
the temporal profile of the immune response to ‘danger signals’
such as LPS in animals fed a spirulina supplemented diet.
We have previously demonstrated that a 4 week spirulina
enriched diet in a one-hour middle cerebral artery occlusion
(MCAO) could reduce the in infarct size by 70% [30]. We also
Figure 5. Spirulina rats have a decreased astrocyte response to LPS. (A) LPS caused a significant increase in the percentage of the dentate
gyrus which was GFAP positive. The spirulina fed rats had a reduced GFAP response LPS compare to the control diet fed rats with LPS. *** p=0.0002
(NIH-31 vs. NIH-31+LPS). {{{ P=0.0003 (NIH-31+LPS vs. spirulina+LPS). (B) There was no significant difference in the total number of GFAP
+ cells. (C)
Representative photomicrograph of the GFAP immunohistochemical staining in the hippocampus. The white arrow points to the area shown in (D)a t
206magnification.
doi:10.1371/journal.pone.0010496.g005
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PLoS ONE | www.plosone.org 6 May 2010 | Volume 5 | Issue 5 | e10496Figure 6. Spirulina increases proliferation of human hematopoetic stem cells in vitro. (A) The effects of spirulina and NT-020 on the
proliferation of human bone marrow cells was examined. Cells were plated in 96 well plates and spirulina at varying concentrations was added to the
culture media. In a separate study shown in the same graph the highest dose of spirulina tested alone (125 ng/ml) was added to NT-020. After
72 hours in culture viability was tested using the MTT assay. Data is expressed at % over control, which are cells grown in media only. When spirulina
is combined with NT-020 the effect is significantly higher than NT-020 alone was more than additive. (B) The effects of spirulina and NT-020 on the
proliferation of human CD34
+ cells was examined. Cells were plated in 96 well plates and spirulina at varying doses was added to the culture media,
in a separate study shown in the same graph the highest dose of spirulina tested alone (125 ng/ml) was added to NT-020. After 72 hours in
culture viability was tested using the MTT assay. Data is expressed at % over control, which is cells grown in media only. When spirulina
is combined with NT-020 the effect is significantly higher than NT-020 alone (p,0.05 students 2-tailed t-test) and the effect appears to be additive.
** p,0.001 ***p,0.0001 (compare to control). P,0.0001 (NT-020 vs. spirulina+NT-020).
doi:10.1371/journal.pone.0010496.g006
Figure 7. Spirulina increases proliferation of human neural stem cells in vitro and protects against a TNFa insult. Human neural
progenitors grown under proliferation conditions were assessed by MTT assay (A) or BrdU (B) for the effects of spirulina (125 ng/ml) or NT-020
(500 ng/ml) or the two treatments combined in the presence or absence of TNFa (20 ng/ml) for 72 hours. (A) The MTT assay shows that spirulina
alone or NT-020 alone increase proliferation; surprising, the in combination proliferation is decrease compare to control ** p,0.005(compare to
media alone). Addition of 20 ng/ml human recombinant TNFa significantly decreased proliferation compare to media alone (***p,0.0001). Only the
addition of spirulina alone was able to revert decrease in proliferation {{{p,0.05 (compare to TNFa alone). (B) Spirulina and NT-020
alone significantly increased the number of BrdU
+ cells. When added together spirulina and NT-020 cause a significant decrease in proliferation
** p,0.005 ***p,0.0001 (compare to media alone). The addition of TNFa significantly decreased proliferation compare to media alone
(***p,0.0001). Spirulina alone was able to prevent the decrease in the number of BrdU
+ cells. {{{ p,0.0001 (compare to TNFa alone).
doi:10.1371/journal.pone.0010496.g007
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Parkinson’s disease. In rats that rats were fed a diet enriched with
spirulina prior to a 6-hydroxydopamine (6-OHDA) lesion spirulina
helped shift the response of microglia to the injury resulting in
improved recovery [31]. At one week after the lesion all the
animals irrespective of diet had a similar lesion volume, but the
spirulina rats had a more robust immune response. At four weeks
after the lesion, the animals that were fed the diet enriched with
spirulina had a significant reduction in lesion volume along with a
significant decrease in microglia activation [31]. These results
suggest spirulina allowed for an early and robust microglia
response, which was beneficial in removing the dead and dying
cells and remodeling the remaining tissue.
Studies of the nutraceutical formulation NT-020 (a combination
of blueberry extract, green tea extract, carnosine, and vitamin D3)
has demonstrated that NT-020 is beneficial in supporting repair
mechanisms following an injury. In an animal model of stroke, NT-
020 was given to theanimals for 2 weeks priorto a MCAO and then
rats were put back on control diets post injury [4]. The NT-020
treatment was shown to prevent damage from the ischemic insult by
70% when compared to control conditions when examined 2 weeks
post stroke. In these same animals it was shown that there was an
increaseinNPCnumbersinboth thestemcellnicheoftheSVZand
atthesiteofinjuryinthe striatum.Thisdata demonstratedthat NT-
020promotestheproliferationofNPCinthenicheandmigrationof
these cells to damaged tissues [4]. This result also shows that the
effects of NT-020 on cellular migration and health last for at least 2
weeks after the nutraceutical is consumed.
Moreover, in a follow-up study, we found that NT-020 reduced
oxidative stress-induced apoptosis of murine neurons and
microglial cells in vitro [32]. Cultured bone marrow stem cells
removed from mice given NT-020 orally for 2 weeks exhibited a
dose-related reduction of oxidative stress-induced cell death. This
demonstrates that the action of this nutraceutical on stem cells is
not dependent on the presence of the formulation as the effect was
observed when the cells were cultured in the absence of NT-020
for 3 days. The data presented here suggest that spirulina added to
NT-020 can increase the proliferative response of bone marrow
and circulating hematopoietic progenitors although the previously
mentioned caveat concerning the MTT assay must be considered
as this is an indirect measure of proliferation. None the less, our
previous studies with spirulina protecting from stroke are very
similar to those reported above for NT-020 where we demonstrate
using direct measures an increase in NPC proliferation in the NT-
020 treatment group.
When the effect of spirulina and NT-020 was examined on
neural progenitors in culture we observed an increase in
proliferation with both spirulina and NT-020 on these cells at
baseline using both the MTT assay and measuring BrdU positive
cells demonstrating that the MTT assay, at least in this case, is a
reflection of increased numbers of cells. Spirulina, but not NT-020
protected against the effect of TNFa to reduce proliferation of
these human neural progenitors in culture. The effect of spirulina
to reduce the effect of TNFa in these cultures may be a
combination of the effect to increase proliferation at baseline
and a direct interaction with the effects of TNFa. Additional
studies would need to be conducted in order to determine the
mechanism of this protection in vitro. The effect of NT-020 and
spirulina appear to differ as they both have effects on baseline, but
only spirulina showed significant effects in the presence of TNFa.
In the current study, we demonstrate that spirulina maintains
regenerative potential of the NPC following an inflammatory
insult. We did not examine the differentiation of these cells into
neurons following spirulina, however the main impact of aging on
NPC’s is to reduce proliferation and thus this remains an
important finding. It would appear that a diet enriched with
spirulina could be beneficial to patient populations at risk for
neurodegenerative disease, by promoting a beneficial immune
response and limiting some the detrimental effects of an over-
active immune system. This study demonstrates an additional
beneficial role of spirulina in maintaining the endogenous repair
mechanisms of NPCs. This study further demonstrates that
spirulina combined with NT-020 can have effects to stimulate
proliferation of other stem cell niches such as the bone marrow.
This effect on the endogenous repair mechanism of the body may
lead to improved health. Although more work is needed to
examine these effects in humans, our data may have clinical
implications insofar as administration of diets enriched in spirulina
or spirulina combined with NT-020 may help maintain our
natural repair mechanisms.
Methods
Animals
All experiments were conducted in accordance with the
National Institute of Health Guide and Use of Laboratory
Animals, and were approved by the Institutional Animal Care
and Use committee of the University of South Florida, College of
Medicine. 3 months old male Fisher 344 (F344) rats (Harlan
Sprague Dawley, Indianapolis, IN), were pair-housed in environ-
mentally controlled conditions (12:12 h light:dark cycle at
2161uC) and provided food and water Ad libitum.
Diet preparation and feeding regimens
NIH-31 (TD 00365; Harlan Teklab, Madison, WI) rodent diet
was used as the control diet. NIH-31 rodent diet was supplemented
with 0.1% Spirulina w/w dry spirulina (Earthrise Co., Petaluma,
CA). Animals were allowed to feed ad libitum for 30 days.
Beginning on day zero until day 30 when the rats were euthanized.
LPS and BrdU injections
On day 28 of the diet animals received a single intraperitoneal
(i.p.) injection of LPS (1 mg/kg, i.p.) or equal volume of saline. On
day 29, two injection of bromodeoxyuridine (BrdU; 5-bromo-2-
deoxyuridine, Sigma, St. Louis, MO, USA) at a dose of 50 mg/kg
of was administered (i.p.) with the second injection 12 hours after
the first. The rats were euthanized, on day 30, 12 hours after the
last injection of BrdU.
Tissue collection and processing
On day 30 all rats were anesthetized with pentobarbital (50 mg/
kg, i.p.). The rats were then perfused transcardialy with phosphate-
buffered saline (PBS), followed by 4% paraformaldehyde in 0.2 M
phosphate-buffered (PB). The brains were postfixed in 4%
paraformaldehyde for 12 hours, after which they were transferred
into 30% sucrose in PB for at least 16 hours at 4uC. Sagital sections
of the left hemisphere were made at 40 mm using a Microm cryostat
(Richard-Allan Scientific, Kalamazoo Michigan), Beginning with a
random start, sections were collected including ‘bookending’
sections where the hippocampus was absent to ensure that the
entire left hippocampus was included in any future analysis. The
brain sections were stored in cryoprotectant at 220uC.
BrdU Immunohistochemistry
BrdU immunohistochemical staining was conducted on free-
floating sections on every sixth section for the entire hippocampus
beginning with a random start and including sections before and
after the hippocampus to ensure that the entire structure was
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(0.3 M NaCl, 0.03 M sodium citrate) at 65uC for 2 hours, rinsed
in 2X SSC, incubated in 2N HCL for 30 minutes at 37uC, rinsed
with borate buffer (pH 8.5), then washed with PBS. This was
followed by quenching endogenous peroxidase activity in 0.3%
H2O2 solution in 30% methanol. The tissue were then blocked for
one hour in PBS supplemented with 3% normal horse serum
(NHS: LAMPIRE Biological Laboratories, Inc. Pipersville, PA;
Cat no. 7333400) and 0.25% Triton X-100 (PBS-TS). BrdU was
detected with the primary mouse anti-BrdU (1:100; Roche;
Indianapolis IN; Cat no. 11 170 376 001, clone BMC 9318)
diluted in PBS-TS. Samples were incubated in Brdu for 18 hours
at 4uC. The following day the sections were washed and then
incubated for one hour in a biotinylated horse Anti-Mouse IgG
(H+L) (Vector Laboratories, Burlingame, CA; Cat no. BA-2001)
at a concentration of 1:200 in PBS-TS. The biotinylated
secondary was amplified in Avidin-biotin substrate (ABC kit,
Vector Laboratories, Burlingame, CA); and then developed in
DAB solution (SIGMA FAST
TM DAB (3,39-Diaminobenzidine
tetrahydrochloride) with Metal Enhancer Tablets Sigma, St.
Louis, MO; Cat no. D4418). Sections were then mounted onto
glass slides and dried overnight. The sections were then counter
stained with Hematoxylin QS (Vector Laboratories, Burlingame,
CA; Cat no. H-3404). The tissue sections were dehydrated
through gradients of ethyl alcohol, and finally xylene. The sections
were then coverslipped with Permount Mounting Medium
(Thermo Fisher Scientific Inc. Cat no. SP15-500).
OX-6 Immunohistochemistry
OX-6 immunohistochemical staining was conducted on free-
floating sections as described above with the following alterations:
Sections were washed three times in PBS, prior to quenching
endogenous peroxidase activity in 0.3% H2O2 solution in 40%
methanol for 20 minutes. Additional washes in PBS preceded a
one hour blocking step in 10% normal horse serum and 0.3%
Triton X-100. A monoclonal antibody directed against the rat
major histocompatibility II (MHC II) (RT1B, Becton, Dickinson
Pharmingen, San Diego, CA; Cat no 557016) was used at a
concentration of 1:750 in PBS-TS. Incubation in the OX-6
antibody was done for 18 hours at 4uC. This was followed by three
washes in PBS supplemented in 3% normal horse serum, before
the addition of a biotinylated horse Anti-Mouse IgG (H+L) (Vector
Laboratories, Burlingame, CA; Cat no. BA-2001) at a concentra-
tion of 1:300 at room temperature for 1 hour in PBS-TS. The
staining proceeded as described for BrdU above.
GFAP Immunohistochemistry
Glial Fibrillary Acidic Protein (GFAP) immunohistochemical
staining was conducted on every 12
th section as described above
with the following alterations: Staining was done in large trays
with a 96 well insert, allowing for 2 brains from each group to be
stained simultaneously. All the brains were stained in one batch, to
limit any batch to batch variability. This was important as GFAP
immunohistochemisty was found to be very sensitive to batch
variations. Sections were washed three times in PBS, prior to
quenching endogenous peroxidase activity in 0.3% H2O2 solution
in 40% methanol for 30 minutes. Additional washes in PBS
preceded a one hour blocking step in 10% normal goat serum
(NGS: LAMPIRE Biological Laboratories, Inc. Pipersville, PA;
Cat no. 7332500) and 0.3% Triton X-100. Polyclonal Rabbit
Anti- GFAP (Dako North America, Inc; Carpinteria, CA; Cat
no. Z0334) was used at a concentration of 1:10,000 diluted in
PBS-TS. Incubation in primary antibody was conducted at 4uC
for 12 hours. This was followed by three washes in PBS-TS. The
secondary antibody, Biotin-SP-AffiniPure Goat Anti-Rabbit IgG
(H+L) (Jackson ImmunoResearch Laboratories, Inc. West Grove,
PA; Cat no. 111-065-144) was diluted in PBS-TS at a concentra-
tion of 1:10,000. The staining proceeded as described for BrdU
above with the exception of the DAB solution which was used
without metal enhancement (SIGMAFAST
TM 3,39-Diaminoben-
zidine tablets, Sigma, St. Louis, MO; Cat no. D4418).
Immunofluorescence
Tissues were pretreated with 2N HCL for 2 hours at room
temperature, washed, and incubated in blocking solution (0.1 M
PBS containing 10% NGS and 0.3% Triton X-100) for 1 hour at
room temperature. Tissues were then incubated in primary
antibodies overnight at 4uC. In addition to rat anti-BrdU
(1:400;Accurate Chemicals, Westbury, NY Cat no OBT003 clone:
BU1/75 (ICR1)) one of the following additional primary antibodies
was added: anti-GFAP (1:500; Dako, Carpinteria, CA), Rabbit anti-
Iba1 (1:500; Wako Chemicals USA, Inc., Richmond, VA; Cat
no. 019-19741); goat anti C-terminus of human Doublecortin
(DCX) (1:200; Santa Cruz biotechnology, Santa Cruz, CA; cat
no. SC-8066). Tissues were then rinsed 3 times in PBS and the
appropriate secondary antibody conjugated to an Alexafluor probe
(Molecular Probes, Eugene, OR) was applied for 2 hour. Following
6 washes in PBS, tissues were mounted on slides and coverslipped
using Vectashield (Vector Labs, Burlingame, CA).
Light microscopy imaging and design-based stereology
Stereological quantifications were made on a Nikon Eclipse 600
microscope using Stereo Investigator software, version 7 (Micro-
BrightField, Colchester, VT). A MBF CX9000 (MicroBrightField,
Colchester, VT) digital camera with a native resolution of
160061200 active pixels was used to visualized samples on a 24
inch Dell 24WFP at 190061200 resolution. LEP Biopoint XYZ
(Ludl Electronic Products Ltd., Hawthorne, NY) motorized stage
was used for XYZ axis movements.
BrdU
The estimated number of BrdU
+ cells was determined using the
optical fractionator method of design-based stereological cell
counting techniques [15]. Every 6
th section throughout the left
hippocampus was used to estimate the number of BrdU
+ cells.
Outlinesofthesubgranularzone(SGZ:defined asatwocelldiameter
band on both sides of the granular cell layer (GCL)) was done using a
10x/0.45 objective. BrdU
+ cell quantification was conducted using a
60x/1.40 objective. The optical dissectors were 100 mm6100 mm.
The grid size was 250 mm6250 mm. These parameters were
established to ensure that a minimum of 200 BrdU
+ cells were
c o u n t e dp e rb r a i nw i t ha ne r r o rc o e f f i c i e n t so fl e s st h a n0 . 0 7 .
OX-6
The estimated number of OX-6
+ cells was quantified for every 6
th
s e c t i o n .T h ea r e as a m p l i n gf r a c t i o nw a ss e ta to n ea st h ee n t i r e
structure was sampled. Using a 10x/0.45 objective the hippocampus
was viewed. OX-6
+ cells found at low power were confirmed using a
40x/0.75 objective to ensure that the cell was not in the first or last
2 mm of the section. The height of the sampling fraction was set at the
averagefoundduringtheBrdUcounts.Onaverageonly20cellswere
found per brain. The number of cells counted was used to estimate
the total number of cells using the optical fractionator formula [15].
GFAP
Cell number was determined using the optical fractionator
method. Outlines of the dentate gyrus, including the SGZ, were
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100 mm6100 mm. The grid size was 500 mm6500 mm. These
parameters were established to ensure that a minimum of 200
GFAP
+ cells were counted per brain with an error coefficients of less
than 0.07. Cell number was quantified using a 40x/0.75 objective.
The designed based stereological probe, Area Fraction Fractionator
(AFF), was used to determine the area fraction of the dentate gyrus
occupied with GFAP
+ staining. The AFF uses the fractionator
method, incorporating an optical dissector with an overlaying
cavalieri point counting lattice to sample a fraction of the entire
structure, in this case the dentate gyrus. GFAP
+ staining was
counted in the Z plane. Such that if a GFAP
+ particle (process or
soma) first appeared after the 2 mm guard, and the GFAP+ particle
intersected with point on the cavalieri lattice, the particle was
counted. If, in the Z plane, the same or different GFAP
+ process
crossed the point of the lattice it was counted. Therefore it could be
possible to have over 100% of the volume of the region of interest to
be positive for staining. However, only the north point of the (+)o f
the lattice was used as an intersection making the point of
intersection small. There was no incidences of two process intersect
with one cavalieri point. We used the Z plane as the GFAP
+ process
are not planner; therefore at any one focal plane some process will
beinfocuswhileotherwillbeoutoffocus.Ifameasurementismade
at only one focal plan, the measurement could be biased by the
selection of that focal plane. AFF, used in this way, does not give a
true absolute volume of the GFAP staining, as you could have more
than 100%. However, quantitative comparison can be made
betweengroups stained inunison. The region counted, the counting
frame, and the grid size for the AFF were the same as used for the
optical fractionator. The cavalieri grid spacing was set at 35 mm.
Laser scanning confocal microscopy
An Olympus FluoView FV1000 laser scanning confocal microscope
was used for all immunofluorescence photomicrographs, only linear
adjustments (brightness and contrast) were made to the figures. When
quantification of percentage of positive cells was determined, Z stacks
were created at 1 mm intervals throughout the 40 mm of the sections
with a guard region of 2 mme x c l u d e df r o mt o pa n db o t t o mo ft h eZ
stack. The Z stacks were rotated in all planes to verify double labeling.
Cell Culture
Cultures of human neural progenitors were maintained in
culture following the supplier’s protocol (HNP1, Neuromics,
Edina, MN). Briefly, immediately after thawing, cells (4610
4
cells/well) were seeded and grown in 96-well plate coated by poly-
L lysine in Neurobasal media (GIBCO, CA) containing 2 mM L-
glutamine, 2% B27 (GIBCO, CA) and 50 U/ml penicillin and
streptomycin for 4 days at 37uC in humidified atmosphere
containing 5% CO2. Human bone marrow cells or human
CD34
+ cells (All Cells, Inc.) were cultured in 96 well plates
(5610
4/well) containing 100 mL of complete medium (RPMI 1640
medium supplemented with 5% FCS). These cells were treated for
72 hours with spirulina at a wide range of doses (15 ng/mL to
500 ng/mL) or NT-020 (proprietary blend of blueberry (500 ng/
ml), green tea (500 ng/ml), vitamin D3 as 25-hydroxycholcalci-
ferol (5 uM) and carnosine (20 uM)) the previously published
effective concentration [14]. Human recombinant TNFa 20 ng/
ml (R&D Systems) was added to human neural cell cultures at the
same time as the other treatments.
MTT assay
Five hours before the end of the treatment, 20 mLo fM T T
solution (MTT kit, Sigma) was added to each well. These plates
were then incubated in a CO
2 incubator at 37uC for 5 hours and
the cultured media removed with needle and syringe. 200 mLo f
DMSO was added to each well with pipetting up and down to
dissolve crystals.These plateswereputbackinto the 37uCincubator
for 5 minutes, transferred to plate reader and absorbance measured
at 550 nm. Data are represented as relative percentage mean
proliferation, defined as O.D. reading number of each treated cells
normalized to control cells (in the absence of treatment).
BrdU immunocytochemistry for cell cultures
Next, in order to reveal the proliferative effects on cultured cells,
BrdU immunocytoreactivities were assayed. Each 8610
4 cells were
plated on 8-well plate coated by poly-L lysine (GIBCO, CA) after
achieving confluence at day 4 in culture. Cultured cells were treated
for 72 hoursas above with the addition of 10 mM BrdU, then rinsed
with phosphate buffered saline (PBS) and fixed with 4%
paraformaldehyde (PFA) for 30 minutes at room temperature.
After blocking reaction with 10% normal goat serum (Vector, CA),
cells were incubated overnight at 4uC with anti-BrdU monoclonal
antibody (1:100, Becton Dickinson, CA) with 10% normal goat
serum. After several rinses in PBS, cells were incubated for 45
minutes at room temperature in FITC-conjugated anti-mouse IgG
(1:1000, Molecular probe, CA). Cells were counterstained with
propidium iodide (PI, cell viability assay) then subsequently
embedded with mounting medium. Immunofluorescent images
were visualized using Zeiss Axiophot 2 and the number of
immunopositive cells was counted per high power field view in 25
fields per well selected at random (50,000 mm
2). In addition, control
studies included exclusion of primary antibody and substituted with
10%normalgoatseruminPBS.Noimmunoreactivitywasobserved
in these controls. All studies were conducted in quadruplicates, with
n=100 fields counted per treatment condition. Assessments were
performed blindly by an independent investigator.
Statistical analyses
Data are presented as mean cell number 6 SEM. Statistical
analysis was performed using an unpaired, two-side t-test, or a
one-way ANOVA followed by an un-paired t-test. A value of
p,0.05 was considered to be significant.
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